hydroxyurea has been researched along with Cancer of the Uterus in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of choriocarcinoma cells (JAr line) for 24 hr with methotrexate, fluorodeoxyuridine, 1-beta-D-arabinofuranosylcytosine, or hydroxyurea, in doses that inhibit DNA synthesis, results in a 2." | 3.66 | Stimulation of human chorionic gonadotropin by JAr line choriocarcinoma after inhibition of DNA synthesis. ( Azizkhan, JC; Goode, D; Speeg, KV; Stromberg, K, 1979) |
| "Oral hydroxyurea (HU) is a potent radiation sensitizer, but in vitro studies have suggested that prolonged exposure to HU by way of continuous parenteral infusion would enhance clinical efficacy." | 2.70 | Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix. ( Anderson, P; Beitler, JJ; Fields, A; Goldberg, G; Haynes, H; Runowicz, CD; Sood, B; Vikram, B; Wadler, S, 2002) |
| "Significant blood eosinophilia is uncommon in leiomyomas and should raise suspicion of malignant etiology for a pelvic mass." | 1.37 | Metastatic uterine leiomyosarcoma and eosinophilia. ( Cheung, WY; Ksienski, D, 2011) |
| "Surgery combined with chemotherapy was applied in 34 out of 178 patients (19." | 1.29 | Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD). ( Kietlińska, Z; Sablińska, B; Zieliński, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolini, F | 1 |
| Cassisa, A | 1 |
| Miggiano, MC | 1 |
| Gasparin, P | 1 |
| Ksienski, D | 1 |
| Cheung, WY | 1 |
| HOWE, CD | 1 |
| SAMUELS, ML | 1 |
| Bagshawe, KD | 3 |
| Weed, JC | 1 |
| Barnard, DE | 1 |
| Currie, JL | 2 |
| Clayton, LA | 1 |
| Hammond, CB | 2 |
| Sablińska, B | 1 |
| Kietlińska, Z | 1 |
| Zieliński, J | 1 |
| Currie, J | 1 |
| Blessing, JA | 3 |
| Muss, HB | 1 |
| Fowler, J | 1 |
| Berman, M | 2 |
| Burke, TW | 1 |
| McGehee, R | 1 |
| Soper, JT | 2 |
| Beitler, JJ | 1 |
| Anderson, P | 1 |
| Haynes, H | 1 |
| Sood, B | 1 |
| Fields, A | 1 |
| Goldberg, G | 1 |
| Vikram, B | 1 |
| Runowicz, CD | 1 |
| Wadler, S | 1 |
| Azizkhan, JC | 1 |
| Speeg, KV | 1 |
| Stromberg, K | 1 |
| Goode, D | 1 |
| Surwit, EA | 1 |
| Suciu, TN | 1 |
| Schmidt, HJ | 1 |
| Brady, LW | 1 |
| Sharma, K | 1 |
| Southall, PJ | 1 |
| Boden, JA | 1 |
| Boxer, GM | 2 |
| Patridge, TA | 1 |
| Antoniw, P | 1 |
| Pedley, RB | 1 |
| Curry, SL | 1 |
| DiSaia, PJ | 1 |
| Twiggs, LB | 1 |
| Bolis, G | 1 |
| Bonazzi, C | 1 |
| Landoni, F | 1 |
| Mangili, G | 1 |
| Vergadoro, F | 1 |
| Zanaboni, F | 1 |
| Mangioni, C | 1 |
| Wong, LC | 1 |
| Choo, YC | 1 |
| Ma, HK | 1 |
| Boden, J | 1 |
| Britton, DW | 1 |
| Green, A | 1 |
| Partridge, T | 1 |
| Pedley, B | 1 |
| Sharma, S | 1 |
| Southall, P | 1 |
2 reviews available for hydroxyurea and Cancer of the Uterus
| Article | Year |
|---|---|
Treatment of high-risk choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cycl | 1984 |
Combined modality therapy of gynecologic cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Evaluation Studies as Topic; Female; Genit | 1975 |
4 trials available for hydroxyurea and Cancer of the Uterus
11 other studies available for hydroxyurea and Cancer of the Uterus
| Article | Year |
|---|---|
Skin nodules in onset of acute myeloid leukemia, a myelomonocytic variant case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Daunorubicin; Delayed Diagnosis; | 2017 |
Metastatic uterine leiomyosarcoma and eosinophilia.
Topics: Antineoplastic Agents; Benzamides; Dyspnea; Eosinophilia; Fatal Outcome; Female; Humans; Hydroxyurea | 2011 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
Topics: Adenocarcinoma; Anemia; Anemia, Aplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Ther | 1964 |
Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease.
Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Dr | 1982 |
Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Chorioca | 1993 |
Stimulation of human chorionic gonadotropin by JAr line choriocarcinoma after inhibition of DNA synthesis.
Topics: Cell Line; Choriocarcinoma; Chorionic Gonadotropin; Cycloheximide; Cytarabine; DNA, Neoplasm; Dose-R | 1979 |
A new combination chemotherapy for resistant trophoblastic disease.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Drug Resistance; Drug Therapy, Combina | 1979 |
Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
Topics: Adenocarcinoma; Animals; Cell Line; Choriocarcinoma; Colon; Colonic Neoplasms; Cytarabine; Drug Resi | 1991 |
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; | 1988 |
Modified Bagshawe's regimen in high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1986 |
A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.
Topics: Animals; Choriocarcinoma; Colon; DNA; Female; Fluorouracil; Humans; Hydroxyurea; Idoxuridine; Methot | 1987 |